2,193 reports of this reaction
3.1% of all BIOTIN reports
#3 most reported adverse reaction
ALOPECIA is the #3 most commonly reported adverse reaction for BIOTIN, manufactured by Guangdong Aimu Biological Technology Co., Ltd. There are 2,193 FDA adverse event reports linking BIOTIN to ALOPECIA. This represents approximately 3.1% of all 70,312 adverse event reports for this drug.
Patients taking BIOTIN who experience alopecia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ALOPECIA is moderately reported among BIOTIN users, representing a notable but not dominant share of adverse events.
In addition to alopecia, the following adverse reactions have been reported for BIOTIN:
The following drugs have also been linked to alopecia in FDA adverse event reports:
ALOPECIA has been reported as an adverse event in 2,193 FDA reports for BIOTIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ALOPECIA accounts for approximately 3.1% of all adverse event reports for BIOTIN, making it one of the most commonly reported side effect.
If you experience alopecia while taking BIOTIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.